Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedative effects of Tolperisone vs Cyclobenzaprine
NCT03353922Phase 1Completed
- Sponsor
- Neurana Pharmaceuticals, Inc.
- Start
- Jul 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tolperisone in Muscle spasm (3 arms), sponsored by Neurana Pharmaceuticals, Inc. Primary endpoint: Standard Deviation of Lateral Position. Started Jul 2017; status: completed.
02
Drugs
tolperisone
03
Conditions
Muscle spasm
Beyond the preview
Go deeper on NCT03353922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03353922.